drug-manufacturing
(4)
Pharmascience Built a Generics Machine. Now It Wants Other Drugmakers to Hire It
The Montreal drugmaker is spending C$119.33 million to triple injectable capacity and sell its know-how to biotech companies. The bet turns an old factory discipline into a new growth engine - if quality and utilization keep pace.
Sun Pharma
Sun Pharma became India’s largest drugmaker by mastering generics. Now a portfolio of skin, eye and cancer medicines - and an audacious pending Organon deal - is changing what the company wants to be.
Neion Bio
Neion Bio is a New York biotech company that genetically engineers chicken eggs into factories for complex biologic drugs. Its Raptor platform aims to make monoclonal antibodies and other glycosylated proteins at a fraction of the capital cost and carbon footprint of conventional cell-culture bioreactors. Founded in 2024 and emerged from stealth in March 2026, the company raised an oversubscribed $23 million Series A in June 2026 and signed an early multi-product biosimilar deal with a major global pharmaceutical company.
Asimov
Asimov is a Boston-based synthetic biology company building computer-aided design (CAD) tools for engineering living cells. Founded in 2017 by bioengineers from MIT and Boston University, it combines mammalian synthetic biology, software, and machine learning through its Kernel platform and 'Edge' production systems to help drug makers design and manufacture cell, gene, and RNA therapies more reliably. The company has raised over $200M, including a $175M Series B in January 2023 led by CPP Investments.